VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ACU
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ACUAcme United Corporation
$48.23$184M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksACUFinancials

Acme United Corporation (ACU) Financials

30Y historyFree accessUpdated daily

Revenue growth remains largely stagnant with a recent 99.9% contraction in 2026Q1, though the company has maintained gross margins near 39% despite volume pressures.

ACU Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue150.64M196.54M194.49M191.5M193.96M182.09M164M142.46M137.32M130.55M124.57M109.81M107.22M89.58M84.37M73.3M63.15M59.15M68.72M63.17M56.86M49.95M43.38M34.97M30.88M36.16M34.41M34.59M36.5M46.3M47.5M
Revenue Growth %-22.95%1.06%1.56%-1.27%6.52%11.03%15.12%3.74%5.19%4.8%13.44%2.42%19.7%6.17%15.1%16.08%6.76%-13.93%8.78%11.1%13.85%15.14%24.03%13.25%-14.6%5.09%-0.5%-5.25%-21.17%-2.53%-9%
Cost of Goods Sold91.12M119.13M118.14M119.29M130.4M117.29M104.41M90.46M86.67M82.65M79.02M70.25M69.04M57.75M54.62M46.98M39.78M37.08M41.06M36.68M32.28M27.59M23.73M21.84M20.45M22.33M22.24M26.09M28.8M34.2M35M
COGS % of Revenue-60.61%60.74%62.29%67.23%64.41%63.66%63.5%63.12%63.31%63.43%63.97%64.39%64.47%64.74%64.09%63%62.68%59.75%58.06%56.77%55.24%54.7%62.45%66.22%61.74%64.61%75.45%78.9%73.87%73.68%
Gross Profit59.51M77.41M76.35M72.21M63.56M64.8M59.59M52M50.65M47.9M45.55M39.56M38.19M31.82M29.75M26.32M23.37M22.07M27.66M26.49M24.58M22.35M19.65M13.13M10.43M13.84M12.18M8.49M7.7M12.1M12.5M
Gross Margin %39.51%39.39%39.26%37.71%32.77%35.59%36.34%36.5%36.88%36.69%36.57%36.03%35.61%35.53%35.26%35.91%37%37.32%40.25%41.94%43.23%44.76%45.3%37.55%33.78%38.26%35.39%24.55%21.1%26.13%26.32%
Gross Profit Growth %-1.39%5.73%13.61%-1.92%8.74%14.6%2.67%5.74%5.15%15.15%3.6%19.99%6.98%13%12.67%5.85%-20.19%4.39%7.77%9.97%13.75%49.65%25.87%-24.6%13.63%43.42%10.27%-36.36%-3.2%-6.72%
Operating Expenses47.21M62.69M62.21M59.02M57.28M52.03M48.18M43.57M43.19M40.1M37.11M32.21M30.79M25.95M24.39M22.04M20.39M19.05M20.78M19.74M17.87M15.51M14.16M10.65M9.53M11.37M9.75M7.61M8.5M11.3M12.7M
OpEx % of Revenue-31.89%31.99%30.82%29.53%28.57%29.38%30.59%31.45%30.72%29.79%29.34%28.72%28.96%28.9%30.07%32.28%32.2%30.24%31.25%31.43%31.06%32.65%30.44%30.85%31.43%28.33%22%23.29%24.41%26.74%
Selling, General & Admin30.74M62.69M62.21M59.02M57.28M52.03M47.93M42.98M43.19M40.1M37.11M32.21M30.79M25.95M24.39M22.04M20.39M19.05M20.78M19.74M17.87M15.51M14.16M10.65M9.53M11.37M9.75M7.61M8.5M11.3M12.7M
SG&A % of Revenue-31.89%31.99%30.82%29.53%28.57%29.23%30.17%31.45%30.72%29.79%29.34%28.72%28.96%28.9%30.07%32.28%32.2%30.24%31.25%31.43%31.06%32.65%30.44%30.85%31.43%28.33%22%23.29%24.41%26.74%
Research & Development000000251K596K734K752K750K690K665K602.99K572.99K0000000000000000
R&D % of Revenue------0.15%0.42%0.53%0.58%0.6%0.63%0.62%0.67%0.68%----------------
Other Operating Expenses1.3M0-1180-246K-196K00-68K25K-76K-168K-118K-35K-99K0000000000000000
Operating Income12.8M14.72M14.14M13.19M6.27M12.77M11.41M8.43M7.46M7.88M8.44M7.35M7.39M5.88M5.36M4.28M2.98M3.03M6.88M6.75M6.71M5.34M5.49M2.49M556.01K2.47M2.43M600K-1M-1.9M-2M
Operating Margin %8.5%7.49%7.27%6.89%3.23%7.01%6.96%5.92%5.43%6.04%6.78%6.69%6.9%6.56%6.35%5.85%4.72%5.12%10.01%10.69%11.81%10.7%12.66%7.11%1.8%6.83%7.06%1.73%-2.74%-4.1%-4.21%
Operating Income Growth %-4.14%7.21%110.23%-50.87%11.89%35.39%13.04%-5.4%-6.62%14.9%-0.64%25.77%9.66%25.11%43.78%-1.55%-56%1.88%0.58%25.66%-2.7%120.82%347.18%-77.49%1.67%304.83%160%47.37%5%73.33%
EBITDA19.39M21.07M20.21M18.26M10.81M16.98M15.25M11.88M10.69M10.78M10.86M9.4M9.09M7.08M6.45M5.26M3.85M3.94M7.89M7.62M7.55M5.99M6.01M2.94M1.12M3.19M3.18M1.6M300K-800K-600K
EBITDA Margin %12.87%10.72%10.39%9.53%5.57%9.32%9.3%8.34%7.78%8.26%8.72%8.56%8.48%7.91%7.65%7.18%6.1%6.67%11.48%12.07%13.27%12%13.86%8.42%3.62%8.83%9.23%4.63%0.82%-1.73%-1.26%
EBITDA Growth %-3.6%4.27%10.7%68.91%-36.33%11.32%28.36%11.18%-0.85%-0.79%15.57%3.36%28.38%9.82%22.55%36.71%-2.4%-49.98%3.46%0.99%25.91%-0.3%104.21%163.25%-64.98%0.49%98.62%433.33%137.5%-33.33%89.29%
D&A (Non-Cash Add-back)4.85M6.35M6.07M5.07M4.54M4.21M3.84M3.45M3.23M2.89M2.42M2.05M1.7M1.2M1.09M978.84K870.16K917.89K1.01M871.25K835.13K652.77K522.35K458.05K562.49K724.01K748.94K1M1.3M1.1M1.4M
EBIT14.67M15.22M14.38M25.83M6.06M16.1M10.77M8.37M7.42M7.85M8.37M7.18M7.29M6M5.44M4.43M3.31M3.61M7.07M6.96M6.96M5M5.5M2.49M905.22K2.47M2.43M600K-1M-1.5M-1.9M
Net Interest Income-1.22M-1.56M-1.94M-2.98M-2.36M-908.22K-919.71K-1.79M-1.86M-1.33M-868.51K-565.21K-473.49K-350.33K-264.4K-254.56K-141.75K-25.67K-395.55K-655.45K-615.5K-234.87K-157.34K-235.26K-605.34K-790.91K-926.95K0-1.5M0-1.5M
Interest Income64.03K123K141.32K119.32K32K14K24.65K40K33K29K1195K17K152K179K149.76K159.56K129K0000000000000
Interest Expense1.29M1.68M2.08M3.1M2.4M922K944.36K1.83M1.89M1.36M869K570K490K502K444K404.33K301.3K155K395.55K655.45K615.5K234.87K157.34K235.26K605.34K790.91K926.95K01.5M01.5M
Other Income/Expense-1.8M-1.61M-1.85M9.55M-2.61M2.4M-1.59M-1.89M-1.93M-1.39M-945.35K-732.61K-591.74K-385.2K-363.47K-258.94K-69.31K426.33K-202.69K-449.09K-363.94K-576.13K-150.13K-144.09K-458.73K-758K-1.33M0-1.4M0-2.6M
Pretax Income11M13.12M12.29M22.73M3.66M15.18M9.83M6.54M5.53M6.49M7.5M6.61M6.8M5.49M5M4.03M2.91M3.45M6.68M6.3M6.35M4.77M5.34M2.34M97.28K1.71M1.1M-182.99K-2.4M-2.7M-3.1M
Pretax Margin %7.3%6.67%6.32%11.87%1.89%8.33%5.99%4.59%4.03%4.97%6.02%6.02%6.34%6.13%5.92%5.49%4.61%5.84%9.72%9.98%11.17%9.54%12.31%6.7%0.32%4.73%3.18%-0.53%-6.58%-5.83%-6.53%
Income Tax2.47M2.93M2.27M4.94M628K1.52M1.73M1.03M933K2.44M1.65M1.82M2.01M1.49M1.45M1.21M337.88K611K2.21M2.28M2.46M1.83M2.1M1.12M-562.22K431.82K35.21K-26.55K0100K100K
Effective Tax Rate %22.44%22.36%18.47%21.74%17.14%10.01%17.58%15.73%16.87%37.59%21.94%27.52%29.6%27.14%28.98%30.17%11.61%17.69%33.09%36.18%38.8%38.37%39.36%47.84%-577.96%25.22%3.21%14.51%0%-3.7%-3.23%
Net Income8.53M10.19M10.02M17.79M3.03M13.66M8.1M5.51M4.6M4.05M5.85M4.79M4.79M4M3.55M2.81M2.57M2.84M4.47M4.02M3.89M2.94M3.24M1.22M659.49K1.28M1.06M2.17M-1.7M200K-3.2M
Net Margin %5.66%5.18%5.15%9.29%1.56%7.5%4.94%3.87%3.35%3.1%4.7%4.37%4.47%4.47%4.21%3.84%4.07%4.8%6.5%6.37%6.83%5.88%7.47%3.49%2.14%3.54%3.08%6.27%-4.66%0.43%-6.74%
Net Income Growth %-15.02%1.62%-43.67%486.31%-77.78%68.61%46.89%19.91%13.47%-30.75%22.05%0.1%19.64%12.79%26.25%9.26%-9.47%-36.38%11.06%3.52%32.29%-9.3%165.05%85.27%-48.49%20.72%-51.09%227.55%-950%106.25%63.22%
Net Income (Continuing)8.53M10.19M10.02M17.79M3.03M13.66M8.1M5.51M4.6M4.05M5.85M4.79M4.79M4M3.55M2.81M2.57M2.84M4.47M4.02M3.89M2.94M3.24M1.22M659.49K1.28M1.06M-200K-2.4M-2.8M-4.7M
Discontinued Operations0000000000000000000000000000000
Minority Interest0000000000000000000000000000000
EPS (Diluted)2.052.492.454.860.823.452.311.601.301.091.641.301.361.221.130.910.810.851.241.091.050.780.850.340.190.360.300.64-0.490.06-0.98
EPS Growth %-5.31%1.63%-49.59%492.68%-76.23%49.35%44.38%23.08%19.27%-33.54%26.15%-4.41%11.48%7.96%24.18%12.35%-4.71%-31.45%13.76%3.81%34.62%-8.24%150%78.95%-47.22%20%-53.13%230.61%-916.67%106.12%61.87%
EPS (Basic)-2.692.714.980.863.932.421.651.361.211.761.441.481.261.140.910.820.861.281.141.110.840.960.370.190.370.300.64-0.490.06-0.98
Diluted Shares Outstanding4.16M4.09M4.1M3.66M3.72M3.96M3.51M3.45M3.54M3.73M3.58M3.69M3.53M3.28M3.13M3.1M3.19M3.35M3.61M3.7M3.7M3.77M3.81M3.59M3.47M3.56M3.54M3.38M3.47M3.35M3.26M
Basic Shares Outstanding3.81M3.79M3.7M3.66M3.53M3.47M3.34M3.35M3.37M3.36M3.33M3.33M3.24M3.17M3.12M3.1M3.13M3.29M3.49M3.54M3.5M3.5M3.37M3.3M3.47M3.46M3.54M3.28M3.47M3.35M3.26M
Dividend Payout Ratio-23.01%22.17%11.2%62.72%13.13%19.81%29.18%32.29%34.76%22.78%25.01%22.22%18.2%30.7%27.45%25.49%23.31%13.31%13.16%11.04%12.97%4.42%--------

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

Stagnant organic revenue growth

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Top Line Growth Remains Stagnant

As reported in financial statements, ACU's revenue growth has remained largely flat, with quarterly fluctuations failing to establish a clear upward trend, evidenced by the 1.9% growth in 2025Q3 and the significant contraction observed in the most recent 2026Q1 period, suggesting limited organic expansion capacity.

The company's inability to consistently grow revenue suggests that its legacy cutting and office segments may be facing saturation or competitive displacement. Investors should monitor whether the reliance on tuck-in acquisitions is masking a lack of underlying demand for the core product portfolio.

Resilient Margins Amidst Volume Pressure

Based on reported figures, ACU has maintained gross margins consistently near the 39% level, demonstrating a degree of pricing power that appears resilient despite the lack of significant top-line growth and the inherent volatility in raw material costs like stainless steel and plastic resins.

This margin stability suggests that the shift toward higher-margin safety and first aid replenishment is successfully offsetting the commoditized nature of the legacy hardware business. However, the company's ability to sustain these levels may be tested if inflationary pressures on medical-grade materials continue to escalate.

Operating Leverage Remains Constrained

According to recent SEC filings, ACU's operating income has shown significant volatility, with operating margins ranging from 3.3% to 11.8% over the last ten quarters, indicating that SG&A expenses are not scaling efficiently with gross profit, thereby limiting the company's overall operating leverage potential.

The lack of consistent operating margin expansion implies that the company may be incurring high fixed costs to support its distribution and compliance infrastructure. This suggests that management's current strategy may prioritize market presence over immediate bottom-line scalability.

Earnings Quality Impacted by Volatility

As indicated by the provided data, ACU's net income has experienced notable swings, including a significant outlier in 2023Q4, which warrants further investigation into the impact of non-operating items and the potential influence of stock-based compensation on the reported earnings per share figures.

The variability in net margins suggests that investors should look past headline EPS to understand the underlying cash-generating capability of the business. The presence of periodic, large-scale stock-based compensation charges may be diluting the quality of earnings and requires careful scrutiny in future reporting periods.

Risks of Structural Margin Compression

While the safety segment provides a defensive moat, the company's reliance on third-party manufacturing and potential exposure to US-China trade tensions, as noted in historical context, suggests that margin compression remains a credible risk if the company cannot pass through rising input costs effectively.

Short-term investors might focus on the stagnant revenue growth as a signal that the company's competitive advantage is weakening. If the safety replenishment cycle fails to scale, the company may be forced to rely on aggressive pricing, which could ultimately erode the brand equity of its legacy products.

ACU — Frequently Asked Questions

Quick answers to the most common questions about buying ACU stock.

What was Acme United Corporation's (ACU) revenue in 2025?

For fiscal year 2025, Acme United Corporation (ACU) reported total revenue of $196.5M. This represents a 313.8% increase compared to $47.5M in 1996.

Is Acme United Corporation (ACU) profitable?

Acme United Corporation (ACU) is profitable, generating $10.2M in net income for the fiscal year ending 2025 with a net profit margin of 5.2%.

What is Acme United Corporation's operating profit margin?

Acme United Corporation (ACU) reported an operating income of $14.7M, resulting in an operating profit margin of 7.5%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Acme United Corporation's gross profit and gross margin?

Acme United Corporation (ACU) generated $77.4M in gross profit for the year, representing a gross profit margin of 39.4%. This demonstrates the company's core pricing power and production efficiency.